Drug Trial Radar · NCT05549297
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Last checked: Nov 20, 2026Latest source record: Feb 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
540
Planned (sponsor's estimate)
Start
Dec 19, 2022
Primary completion
Mar 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- Immunocore LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of tebentafusp-based regimens, including tebentafusp monotherapy and in combination with anti-PD1 vs investigator choice (including clinical trials of investigational agents, salvage therapy per local standard of care \[SoC\], best supportive care \[BSC\] on protocol survivor follow up) in patients with advanced non-ocular melanoma.
Conditions
- Advanced Melanoma
Interventions
TebentafuspDrug
Soluble gp100-specific T cell receptor with anti-CD3 scFV
Tebentafusp with PembrolizumabDrug
Soluble gp100-specific T cell receptor with anti-CD3 scFV in combination with pembrolizumab
Investigators ChoiceDrug
Investigators choice of therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: Up to ~4 years
Locations
82 sites in 12 countries. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Phoenix, Arizona · Recruiting
Mayo Clinic Florida
Jacksonville, Florida · Recruiting
Orlando Health Cancer Institute
Orlando, Florida · Recruiting
Winship Cancer Institute of Emory University
Atlanta, Georgia · Recruiting
University of Kansas Cancer Center - Westwood
Westwood, Kansas · Recruiting
St Elizabeth Healthcare (St Elizabeth Medical Center)
Edgewood, Kentucky · Recruiting
St Elizabeth Healthcare (St Elizabeth Medical
Edgewood, Kentucky · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
University of Minnesota Medical Center
Minneapolis, Minnesota · Recruiting
Mayo Clinic Minnesota
Rochester, Minnesota · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey · Recruiting
Northwell Health Cancer Institute - Zuckerberg Cancer Center
Lake Success, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma · Recruiting
Thomas Jefferson University Medical Oncology Clinic
Philadelphia, Pennsylvania · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Gibbs Cancer Center and Research Institute
Spartanburg, South Carolina · Recruiting
University of Tennessee Medical Center
Knoxville, Tennessee · Recruiting
Houston Methodist Hospital/Houston Methodist Cancer Center
Houston, Texas · Recruiting
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Melanoma Institute Australia
Wollstonecraft, New South Wales, Australia · Recruiting
Gallipoli Medical Research Foundation (GMRF)
Greenslopes, Queensland, Australia · Recruiting
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia · Recruiting
Alfred Health
Melbourne, Victoria, Australia · Recruiting
LKH - Universitaetsklinikum Graz
Graz, Austria · Recruiting
Kepler Universitätsklinikum
Linz, Austria · Recruiting
Universitatsklinik fur Innere Medizin 3
Salzburg, Austria · Recruiting
AKH - Medizinische Universität Wien
Vienna, Austria · Recruiting
Cliniques Universitaires Sain-Luc
Brussels, Belgium · Recruiting
UZ Brussel
Jette, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
BC Cancer
Vancouver, British Columbia, Canada · Recruiting
Princess Margaret Hospital
Toronto, Ontario, Canada · Recruiting
Lady Davis Institute for Medical Research (LDI) Jewish General Hospital (JGH)
Montreal, Quebec, Canada · Recruiting
CHU de Bordeaux - Hopital Saint Andre
Bordeaux, France · Recruiting
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.